Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial
Israeli, E., Goldin, E., Fishman, S., Konikoff, F., Lavy, A., Chowers, Y., Melzer, E., Lahat, A., Mahamid, M., Shirin, H., Nussinson, E., Segol, O., Ben Ya'acov, A., Shabbat, Y., Ilan, Y.Volume:
181
Language:
english
Journal:
Clinical & Experimental Immunology
DOI:
10.1111/cei.12640
Date:
August, 2015
File:
PDF, 311 KB
english, 2015